A blood drive was held in Arizona to honor Paula Off, who gave blood more than 300 times before she died of cancer ...

Study in adults and children with aplastic anemia identifies parallel evolutionary pathways used by hematopoietic stem cells ...

Aplastic anemia is a rare, life-threatening blood disorder where patients are unable to make enough blood cells due to the ...

Aplastic anemia is a rare blood disorder in which patients cannot make enough blood cells. This life-threatening disease is a ...

A Prescription Drug User Fee Act target date of December 10, 2025 has been set for the application. The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics ...

On the surface, Owen Ho looked fine. But on the inside, it was a different story. Ho, 42, was exhausted. He couldn’t muster up the strength to exercise even though months earlier, six-hour bike rides ...

What Is Omisirge, and Why Does It Matter? Omisirge (omidubicel-onlv) is a type of cell therapy made from umbilical cord blood. It helps your body make new blood cells after a stem cell transplant.

Experts provide an update regarding current understanding and management of aplastic anemia in a new review. 1 Eliska Furlong, MD, PhD, with the Perth Children’s Hospital, in Australia, and colleague ...

Please provide your email address to receive an email when new articles are posted on . Prior trials established the role of haploidentical BMT for severe aplastic anemia. Two trials underway have the ...

For first-line treatment of severe aplastic anemia, adding eltrombopag (Promacta) to standard immunosuppressive therapy improved the rate, speed, and depth of hematologic response in the phase III ...